Strata Oncology, a start-up company, wants to test 100,000 cancer patients in the hope to identify rare DNA faults so that they can be directed to the best pharmaceutical company for treatment. The idea is not new. Rhodes says his company intends to partner with smaller hospitals so they can also offer DNA sequencing to every patient as well. Similar tests are already offered, but Strata's unorthodox business plan hopes to eliminate the issue of DNA testing cancer cells as an experimental procedure, where insurers will refuse to pay out for patients for this reason.
Strata Oncology, a start-up company, wants to test 100,000 cancer patients in the hope to identify rare DNA faults so that they can be directed to the best pharmaceutical company for treatment. The idea is not new. Similar tests are already offered, but Strata's unorthodox business plan hopes to eliminate the issue of DNA testing cancer cells as an experimental procedure, where insurers will refuse to pay out for patients for this reason.